Robert Kaner, MD
Pulmonary Disease · New York, NYNPI 1205923380
Payments from drug & device makers
Across 331 payments — averaging $6977.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$2.1M
- CSL Behring$79K
- Boehringer Ingelheim International GmbH$75K
- Chiesi USA, Inc.$25K
- Genentech USA, Inc.$15K
- United Therapeutics Corporation$12K
- plus $17K from 7 others
Across 5 payments — averaging $1544.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$8K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 100 | $2,086,466 |
| CSL Behring | 33 | $78,545 |
| Boehringer Ingelheim International GmbH | 98 | $75,453 |
| Chiesi USA, Inc. | 1 | $24,875 |
| Genentech USA, Inc. | 17 | $14,580 |
| United Therapeutics Corporation | 41 | $12,421 |
| Amgen | 1 | $10,976 |
| AstraZeneca | 3 | $3,523 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 26 | $1,686 |
| Boehringer Ingelheim Limited | 7 | $891 |
| Genentech, Inc. | 1 | $50 |
| GSK | 2 | $42 |
| Viatris Specialty LLC | 1 | $31 |
How this compares
$2,309,538 in reported general payments places this provider in the 95th percentile of 1,115 pulmonary disease providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in New York
- Linda RogersNew York$7.1M
- Maria PadillaNew York$3.6M
- Juan WisniveskyNew York$3M
- Bushra MinaNew York$2.5M
- Doreen Addrizzo-HarrisNew York$1.9M
- Emily DimangoNew York$1.4M
- da ZhangNew York$1.3M
- Claire KeatingNew York$1.2M
- Charles PowellNew York$1M
- Ronald CrystalNew York$886K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.